SCHEMBL18398658

SCHEMBL18398658

O=C(NOC(=O)C1CCCC(F)(F)C1)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.46
ALDH1A1 P00352 5/20 0.44
GAA P10253 1/20 0.44
DPP4 P27487 1/20 0.43
KCNH2 Q12809 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CPB1 P15086 1/20 0.42
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
CYP3A4 P08684 6/20 0.41
EPHX1 P07099 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2C9 P11712 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29129479 0.84 TSHR (0.54) TSHRALDH1A1GAACA12CA1
SCHEMBL28595580 0.84 TSHR (0.54) TSHRALDH1A1GAACA12CA1
SCHEMBL5674337 0.83 ALDH1A1 (0.54) TSHRALDH1A1GAACA12CA1
SCHEMBL145262 0.81 TSHR (0.60) TSHRALDH1A1GAACA12CA1
SCHEMBL3617827 0.79 SLC6A2 (0.45) TSHRALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL15457715 0.79 SLC6A2 (0.45) TSHRALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL8243727 0.79 EPHX1 (0.58) TSHRALDH1A1GAADPP4KCNH2
SCHEMBL21057414 0.79 EPHX1 (0.58) TSHRALDH1A1GAADPP4KCNH2
SCHEMBL21057485 0.79 EPHX1 (0.58) TSHRALDH1A1GAADPP4KCNH2
SCHEMBL29385701 0.76 TSHR (0.51) TSHRALDH1A1GAACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661931-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-06-10 EP disclosed
WO-2019027054-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-02-07 WO disclosed
EP-3325475-A1 OXADIAZOLE DERIVATIVES USEFUL AS HDAC INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2018-05-30 EP disclosed
WO-2017014321-A1 OXADIAZOLE DERIVATIVES USEFUL AS HDAC INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-01-26 WO disclosed